{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:18:36Z","timestamp":1776705516663,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejim.2023.09.013","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T11:20:11Z","timestamp":1695036011000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Legionella pneumonia in hospitalized adults with respiratory failure: Quinolones or macrolides?"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4335-4645","authenticated-orcid":false,"given":"Alfonsina","family":"Ruiz-Spinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2023.09.013_bib0001","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40121-022-00635-7","article-title":"Legionnaires\u2019 disease: update on diagnosis and treatment","volume":"11","author":"Viasus","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ejim.2023.09.013_bib0002","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(15)60078-2","article-title":"Legionnaires\u2019 disease","volume":"387","author":"Cunha","year":"2016","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.ejim.2023.09.013_bib0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.JAA.0000873792.00538.78","article-title":"Legionella: an uncommon cause of community-acquired pneumonia","volume":"35","author":"Barimani","year":"2022","journal-title":"JAAPA"},{"key":"10.1016\/j.ejim.2023.09.013_bib0004","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1093\/cid\/civ157","article-title":"The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia","volume":"60","author":"Gershengorn","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2023.09.013_bib0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0885066617700121","article-title":"Outcome and management of refractory respiratory failure with timely extracorporeal membrane oxygenation: single-center experience with Legionella pneumonia","volume":"34","author":"Roncon-Albuquerque","year":"2019","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.ejim.2023.09.013_bib0006","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.medin.2012.05.010","article-title":"Community-acquired Legionella pneumonia in the intensive care unit: impact on survival of combined antibiotic therapy","volume":"37","author":"Rello","year":"2013","journal-title":"Med Intensiva"},{"key":"10.1016\/j.ejim.2023.09.013_bib0007","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/cid\/ciaa441","article-title":"Are fluoroquinolones or macrolides better for treating Legionella pneumonia? a systematic review and meta-analysis","volume":"72","author":"Jasper","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2023.09.013_bib0008","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/jac\/dkx007","article-title":"Antimicrobial strategy for severe community-acquired legionnaires\u2019 disease: a multicentre retrospective observational study","volume":"72","author":"Cecchini","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2023.09.013_bib0009","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/microorganisms11020498","article-title":"Legionella pneumophila infections during a 7-year retrospective analysis (2016\u20132022): epidemiological, clinical features and outcomes in patients with Legionnaires\u2019 disease","volume":"11","author":"Lupia","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejim.2023.09.013_bib0010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.medmal.2006.07.020","article-title":"13\u2013Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents","volume":"36","author":"Roig","year":"2006","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ejim.2023.09.013_bib0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkg191","article-title":"Legionnaires\u2019 disease: a rational approach to therapy","volume":"51","author":"Roig","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2023.09.013_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.10.009","article-title":"Community-acquired pneumonia - an EFIM guideline critical appraisal adaptation for internists","volume":"106","author":"Er","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"12 Suppl 3","key":"10.1016\/j.ejim.2023.09.013_bib0013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2006.01394.x","article-title":"Legionella: macrolides or quinolones?","author":"Pedro-Botet","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2023.09.013_bib0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-0691.2006.01393.x","article-title":"The atypical pneumonias: clinical diagnosis and importance","volume":"12 Suppl 3","author":"Cunha","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2023.09.013_bib0015","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/17843286.2021.1978211","article-title":"Clinical features of legionnaires\u2019 disease at three Belgian University Hospitals, a retrospective study","volume":"77","author":"Moretti","year":"2022","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.ejim.2023.09.013_bib0016","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmi.2017.02.030","article-title":"Levofloxacin versus azithromycin for treating Legionella pneumonia: a propensity score analysis","volume":"23","author":"Garcia-Vidal","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2023.09.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106481","article-title":"Treatment of Legionellosis including a single intravenous dose of 1.5 g azithromycin: 18-year experience at a tertiary care hospital","volume":"59","author":"Karer","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2023.09.013_bib0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MD.0b013e31827f6104","article-title":"Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years","volume":"92","author":"Viasus","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2023.09.013_bib0019","first-page":"203","article-title":"Retrospective analysis of azithromycin versus fluoroquinolones for the treatment of Legionella pneumonia","volume":"39","author":"Nagel","year":"2014","journal-title":"P T"},{"key":"10.1016\/j.ejim.2023.09.013_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmii.2016.08.006","article-title":"Legionnaires\u2019 disease at a medical center in Southern Taiwan","volume":"51","author":"Hung","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ejim.2023.09.013_bib0021","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jmii.2017.08.018","article-title":"Community-acquired Legionnaires\u2019 disease at a medical center in Northern Taiwan","volume":"52","author":"Kao","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ejim.2023.09.013_bib0022","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jiac.2020.10.002","article-title":"Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia","volume":"27","author":"Kato","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ejim.2023.09.013_bib0023","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","volume":"37","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523003333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523003333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:38:26Z","timestamp":1715899106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523003333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"alternative-id":["S0953620523003333"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.09.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Legionella pneumonia in hospitalized adults with respiratory failure: Quinolones or macrolides?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}